Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 549

1.

What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?

Diamond IR, Pencharz PB, Wales PW.

Minerva Pediatr. 2009 Jun;61(3):263-72. Review.

PMID:
19461570
2.

Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.

Angsten G, Finkel Y, Lucas S, Kassa AM, Paulsson M, Lilja HE.

JPEN J Parenter Enteral Nutr. 2012 Sep;36(5):587-95. doi: 10.1177/0148607111430507.

PMID:
22275330
3.

Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil.

Fallon EM, Le HD, Puder M.

Curr Opin Organ Transplant. 2010 Jun;15(3):334-40. Review.

PMID:
20503524
4.

The use of Omegaven in treating parenteral nutrition-associated liver disease.

Park KT, Nespor C, Kerner J Jr.

J Perinatol. 2011 Apr;31 Suppl 1:S57-60. doi: 10.1038/jp.2010.182.

PMID:
21448206
5.

Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.

Xu Z, Li Y, Wang J, Wu B, Li J.

Clin Nutr. 2012 Apr;31(2):217-23. doi: 10.1016/j.clnu.2011.10.001.

PMID:
22035955
6.

Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.

Gura KM, Lee S, Valim C, Zhou J, Kim S, Modi BP, Arsenault DA, Strijbosch RA, Lopes S, Duggan C, Puder M.

Pediatrics. 2008 Mar;121(3):e678-86. doi: 10.1542/peds.2007-2248.

PMID:
18310188
7.

Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience.

de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M.

JPEN J Parenter Enteral Nutr. 2009 Sep-Oct;33(5):541-7. doi: 10.1177/0148607109332773. Review.

PMID:
19571170
8.

Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.

Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS.

Nutr Clin Pract. 2010 Apr;25(2):199-204. doi: 10.1177/0884533610361477. Erratum in: Nutr Clin Pract. 2010 Jun;25(3):315.

PMID:
20413701
9.

The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease.

Diamond IR, Sterescu A, Pencharz PB, Wales PW.

Pediatr Surg Int. 2008 Jul;24(7):773-8. doi: 10.1007/s00383-008-2174-0. Review.

PMID:
18504595
10.

Omega-3 lipids for intestinal failure associated liver disease.

Diamond IR, Pencharz PB, Wales PW.

Semin Pediatr Surg. 2009 Nov;18(4):239-45. doi: 10.1053/j.sempedsurg.2009.07.005. Review.

PMID:
19782305
11.

Total parenteral nutrition in patients with short bowel syndrome.

Ekema G, Milianti S, Boroni G.

Minerva Pediatr. 2009 Jun;61(3):283-91. Review.

PMID:
19461572
12.

Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children.

Le HD, de Meijer VE, Robinson EM, Zurakowski D, Potemkin AK, Arsenault DA, Fallon EM, Malkan A, Bistrian BR, Gura KM, Puder M.

Am J Clin Nutr. 2011 Sep;94(3):749-58. doi: 10.3945/ajcn.110.008557.

13.

Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.

Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M.

Pediatrics. 2006 Jul;118(1):e197-201.

PMID:
16818533
14.

Is the use of parenteral omega-3 lipid emulsions justified in surgical neonates with mild parenteral nutrition-associated liver dysfunction?

Nasr A, Diamond IR, de Silva NT, Wales PW.

J Pediatr Surg. 2010 May;45(5):980-6. doi: 10.1016/j.jpedsurg.2010.02.027.

PMID:
20438939
15.

Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.

Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):209-15. doi: 10.1097/MPG.0b013e318182c8f6.

PMID:
19179884
16.

Parenteral fish oil as monotherapy for patients with parenteral nutrition-associated liver disease.

de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M.

Pediatr Surg Int. 2009 Jan;25(1):123-4. doi: 10.1007/s00383-008-2255-0. No abstract available.

PMID:
18828026
17.

The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.

Venick RS, Calkins K.

Curr Opin Organ Transplant. 2011 Jun;16(3):306-11. doi: 10.1097/MOT.0b013e32834670eb. Review.

PMID:
21505340
18.

Fish oil containing intravenous lipid emulsions in parenteral nutrition-associated cholestatic liver disease.

Koletzko B, Goulet O.

Curr Opin Clin Nutr Metab Care. 2010 May;13(3):321-6. doi: 10.1097/MCO.0b013e3283385407. Review.

PMID:
20393276
19.

Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.

Puder M, Valim C, Meisel JA, Le HD, de Meijer VE, Robinson EM, Zhou J, Duggan C, Gura KM.

Ann Surg. 2009 Sep;250(3):395-402. doi: 10.1097/SLA.0b013e3181b36657.

20.

Fish oil lipid emulsions and immune response: what clinicians need to know.

Waitzberg DL, Torrinhas RS.

Nutr Clin Pract. 2009 Aug-Sep;24(4):487-99. doi: 10.1177/0884533609339071. Review.

PMID:
19605803

Supplemental Content

Support Center